Donald Trump announced a discounted drug program for Medicare recipients, which is currently undergoing financial feasibility review by the Congressional Budget Office.
Steady: 0 in the last 7 days
Updated sep 17
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Donald Trump announced a discounted drug program for Medicare recipients, which is currently undergoing financial feasibility review by the Congressional Budget Office.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Trump promised drug discounts for low-income Americans and discussed Pfizer deals at a Dallas convention.Sub-event
- Republicans established a drug discount program, while industry groups like PhRMA saw members like Purdue Pharma involved, as Trump sought to counter industry moves.Sub-event
- Ionis Pharmaceuticals has been invited to participate in new Medicaid arrangements, coinciding with Donald Trump's promise of globally cheapest drug prices.Sub-event
- A tax bill containing major cuts was passed, affecting the discounted drug program for Medicare recipients, with implementation advised by policy experts and executed via CMS.Sub-event
Trump proposes a discounted drug program for Medicare recipients, pending CBO feasibility review.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Medicare
US federal health insurance
-
Congressional Budget Office
government agency